Metabolomics and bladder cancer

Matthew E. Hyndman, Jeffrey K. Mullins, Trinity Bivalacqua

Research output: Contribution to journalArticle

Abstract

Diagnosis of bladder cancer is primarily made based on clinical presentation and then by direct visualization with cystoscopy. Despite the massive investments recently made to identify urinary-based assays that are able to diagnosis urothelial carcinoma, urine cytology and cystoscopy still remain the gold standard. Recently proof of principle studies have shown that noninvasive urine-based metabolomics, using high pressure liquid chromatography (HPLC) and nuclear magnetic resonance (NMR), may be able to accurately diagnosis bladder cancer. This review discuses the published studies investigating metabolomics and bladder cancer and the future potential of this developing field.

Original languageEnglish (US)
Pages (from-to)558-561
Number of pages4
JournalUrologic Oncology: Seminars and Original Investigations
Volume29
Issue number5
DOIs
StatePublished - Sep 2011

Fingerprint

Metabolomics
Urinary Bladder Neoplasms
Cystoscopy
Urine
Cell Biology
Magnetic Resonance Spectroscopy
High Pressure Liquid Chromatography
Carcinoma

Keywords

  • Bladder cancer
  • Cystoscopy
  • Cytology
  • Diagnosis
  • HPLC
  • Metabolomics
  • NMR
  • Review
  • Urine

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

Metabolomics and bladder cancer. / Hyndman, Matthew E.; Mullins, Jeffrey K.; Bivalacqua, Trinity.

In: Urologic Oncology: Seminars and Original Investigations, Vol. 29, No. 5, 09.2011, p. 558-561.

Research output: Contribution to journalArticle

Hyndman, Matthew E. ; Mullins, Jeffrey K. ; Bivalacqua, Trinity. / Metabolomics and bladder cancer. In: Urologic Oncology: Seminars and Original Investigations. 2011 ; Vol. 29, No. 5. pp. 558-561.
@article{829f7368df7b40a1b67fc7cbb334946f,
title = "Metabolomics and bladder cancer",
abstract = "Diagnosis of bladder cancer is primarily made based on clinical presentation and then by direct visualization with cystoscopy. Despite the massive investments recently made to identify urinary-based assays that are able to diagnosis urothelial carcinoma, urine cytology and cystoscopy still remain the gold standard. Recently proof of principle studies have shown that noninvasive urine-based metabolomics, using high pressure liquid chromatography (HPLC) and nuclear magnetic resonance (NMR), may be able to accurately diagnosis bladder cancer. This review discuses the published studies investigating metabolomics and bladder cancer and the future potential of this developing field.",
keywords = "Bladder cancer, Cystoscopy, Cytology, Diagnosis, HPLC, Metabolomics, NMR, Review, Urine",
author = "Hyndman, {Matthew E.} and Mullins, {Jeffrey K.} and Trinity Bivalacqua",
year = "2011",
month = "9",
doi = "10.1016/j.urolonc.2011.05.014",
language = "English (US)",
volume = "29",
pages = "558--561",
journal = "Urologic Oncology",
issn = "1078-1439",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Metabolomics and bladder cancer

AU - Hyndman, Matthew E.

AU - Mullins, Jeffrey K.

AU - Bivalacqua, Trinity

PY - 2011/9

Y1 - 2011/9

N2 - Diagnosis of bladder cancer is primarily made based on clinical presentation and then by direct visualization with cystoscopy. Despite the massive investments recently made to identify urinary-based assays that are able to diagnosis urothelial carcinoma, urine cytology and cystoscopy still remain the gold standard. Recently proof of principle studies have shown that noninvasive urine-based metabolomics, using high pressure liquid chromatography (HPLC) and nuclear magnetic resonance (NMR), may be able to accurately diagnosis bladder cancer. This review discuses the published studies investigating metabolomics and bladder cancer and the future potential of this developing field.

AB - Diagnosis of bladder cancer is primarily made based on clinical presentation and then by direct visualization with cystoscopy. Despite the massive investments recently made to identify urinary-based assays that are able to diagnosis urothelial carcinoma, urine cytology and cystoscopy still remain the gold standard. Recently proof of principle studies have shown that noninvasive urine-based metabolomics, using high pressure liquid chromatography (HPLC) and nuclear magnetic resonance (NMR), may be able to accurately diagnosis bladder cancer. This review discuses the published studies investigating metabolomics and bladder cancer and the future potential of this developing field.

KW - Bladder cancer

KW - Cystoscopy

KW - Cytology

KW - Diagnosis

KW - HPLC

KW - Metabolomics

KW - NMR

KW - Review

KW - Urine

UR - http://www.scopus.com/inward/record.url?scp=80052918426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052918426&partnerID=8YFLogxK

U2 - 10.1016/j.urolonc.2011.05.014

DO - 10.1016/j.urolonc.2011.05.014

M3 - Article

C2 - 21930087

AN - SCOPUS:80052918426

VL - 29

SP - 558

EP - 561

JO - Urologic Oncology

JF - Urologic Oncology

SN - 1078-1439

IS - 5

ER -